相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
Lee-Lee Lai et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease
Li-Wei Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B
Hannah S. J. Choi et al.
HEPATOLOGY (2020)
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Fei Chen et al.
HEPATOLOGY (2020)
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
Felix Stickel et al.
HEPATOLOGY (2020)
Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
Tony (Dazhong) Huang et al.
INTERNAL MEDICINE JOURNAL (2020)
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETES CARE (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Epidemiological Features of NAFLD From 1999 to 2018 in China
Jianghua Zhou et al.
HEPATOLOGY (2020)
The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis
Yuankai Wu et al.
HEPATOLOGY INTERNATIONAL (2020)
Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
Mohammad Shadab Siddiqui et al.
JOURNAL OF HEPATOLOGY (2020)
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Effects of sodium-glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Baodi Xing et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Metabolic Inflammation and Insulin Resistance in Obesity
Huaizhu Wu et al.
CIRCULATION RESEARCH (2020)
Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars
Sion A. Parry et al.
DIABETES CARE (2020)
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Federica Zatterale et al.
FRONTIERS IN PHYSIOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
Jing Zeng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study
Takuro Okamura et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Macrophage Subsets in Obesity, Aligning the Liver and Adipose Tissue
Anneleen Remmerie et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
Tran Thi Khanh Tuong et al.
DIAGNOSTICS (2020)
Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
Shengliang Xin et al.
BMC GASTROENTEROLOGY (2020)
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
Dae Ho Lee
ENDOCRINOLOGY AND METABOLISM (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance
Evan C. Ray
CURRENT OPINION IN PHARMACOLOGY (2020)
Medical liver biopsy: background, indications, procedure and histopathology
Alexander Boyd et al.
FRONTLINE GASTROENTEROLOGY (2020)
Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor
Rocio Aller et al.
ENDOCRINE (2020)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes
Ming-Feng Xia et al.
DIABETOLOGIA (2019)
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease
Jie Yang et al.
HEPATOLOGY (2019)
Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice
Nina L. Gluchowski et al.
HEPATOLOGY (2019)
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
Philip Newsome et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Eduardo Vilar-Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Fernando Bril et al.
DIABETES CARE (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
Paul J. Pockros et al.
LIVER INTERNATIONAL (2019)
Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
Meng Jiang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
Jia-Zhen Zhang et al.
GENE EXPRESSION (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease
Yanling Ma et al.
HEPATOLOGY (2019)
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
Fernando Bril et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
Golnaz Ranjbar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Sven Francque et al.
ADVANCES IN THERAPY (2019)
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Sneha Kothari et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Eun-Jung Rhee
ENDOCRINOLOGY AND METABOLISM (2019)
Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis
Biaoyang Lin et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis
B. Hameed et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Non-alcoholic fatty liver disease
James Maurice et al.
CLINICAL MEDICINE (2018)
The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom
Nadege T. Gunn et al.
CLINICS IN LIVER DISEASE (2018)
Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Yonah B. Esterson et al.
CLINICS IN LIVER DISEASE (2018)
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People
Yuanjie Pang et al.
HEPATOLOGY (2018)
The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)
Laura Iogna Prat et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
Gyuri Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen et al.
JOURNAL OF HEPATOLOGY (2018)
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
Laurent Castera
LIVER INTERNATIONAL (2018)
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
Anubha Mahajan et al.
NATURE GENETICS (2018)
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
N. S. Abul-Husn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity
Antonio Sergio Barcala Jorge et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2018)
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model
Yan-Lan Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Richard E. Pratley et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
Bernhard Ludvik et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
Hisamitsu Ishihara et al.
DIABETES THERAPY (2018)
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
Hisamitsu Ishihara et al.
DIABETES THERAPY (2018)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
Alexandra Feldman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
The Membrane-Bound O-Acyltransferase Domain-Containing 7 Variant rs641738 Increases Inflammation and Fibrosis in Chronic Hepatitis B
Khaled Thabet et al.
HEPATOLOGY (2017)
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2017)
Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
Dominique Roulot et al.
LIVER INTERNATIONAL (2017)
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
Max C. Petersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
Kasper W. ter Horst et al.
CELL REPORTS (2017)
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Dong Ho Lee
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
Kenneth Cusi et al.
DIABETES OBESITY & METABOLISM (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Rosellina Margherita Mancina et al.
GASTROENTEROLOGY (2016)
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
Kento Imajo et al.
GASTROENTEROLOGY (2016)
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes
Mohammed Eslam et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome
Ivana Mikolasevic et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Khaled Thabet et al.
NATURE COMMUNICATIONS (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomized, placebo-controlled phase 2 study
Jaimini Cegla
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Non-alcoholic Fatty Liver Disease (NAFLD) and Significant Hepatic Fibrosis Defined by Non-invasive Assessment in Patients with Type 2 Diabetes
Abhasnee Sobhonslidsuk et al.
Asian Pacific Journal of Cancer Prevention (2015)
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease
Paola Dongiovanni et al.
HEPATOLOGY (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening
Xueyao Yin et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Stephan Buch et al.
NATURE GENETICS (2015)
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
Ken Sato et al.
NUTRITION (2015)
Targeting endoplasmic reticulum stress in insulin resistance
Laia Salvado et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Proton magnetic resonance spectroscopy reveals increased hepatic lipid content after a single high-fat meal with no additional modulation by added protein
Lucas Lindeboom et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Amedeo Lonardo et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
The Impact of Obesity and Metabolic Syndrome on Alcoholic Liver Disease
Dian J. Chiang et al.
CLINICS IN LIVER DISEASE (2014)
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Andreas L. Birkenfeld et al.
HEPATOLOGY (2014)
Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats
Alba Rebollo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau et al.
CURRENT DIABETES REPORTS (2013)
Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
Giovanni Musso et al.
DIABETES (2013)
Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding
N. Turner et al.
DIABETOLOGIA (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
Kandaswamy Ramya et al.
GENE (2013)
Patatin-Like Phospholipase Domain-Containing 3 I148M Affects Liver Steatosis in Patients With Chronic Hepatitis B
Mauro Vigano et al.
HEPATOLOGY (2013)
Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
Motoi Hashiba et al.
PLOS ONE (2013)
Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk
M. G. Rees et al.
DIABETOLOGIA (2012)
High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism
Lisa Longato et al.
HEPATOLOGY RESEARCH (2012)
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
John Zhong Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
Carlo Pirazzi et al.
JOURNAL OF HEPATOLOGY (2012)
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2012)
Visceral fat and metabolic inflammation: the portal theory revisited
F. Item et al.
OBESITY REVIEWS (2012)
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Temitope Foster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C
Luca Valenti et al.
HEPATOLOGY (2011)
Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis
Ruben Hernaez et al.
HEPATOLOGY (2011)
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
Mahesh K. Basantani et al.
JOURNAL OF LIPID RESEARCH (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Francois R. Jornayvaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
Elizabeth K. Speliotes et al.
PLOS GENETICS (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Maria Stepanova et al.
GUT (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Shijie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Transcription Factor 7-Like 2 Polymorphism Modulates Glucose and Lipid Homeostasis, Adipokine Profile, and Hepatocyte Apoptosis in NASH
Giovanni Musso et al.
HEPATOLOGY (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
The common P446L polymorphism in GCAR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
Martine Vaxillaire et al.
DIABETES (2008)
Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH
Giovanni Musso et al.
HEPATOLOGY (2008)
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Valeriya Lyssenko et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice
Renaud Dentin et al.
DIABETES (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2
DB Savage et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
A Gastaldelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease
EM Brunt et al.
MODERN PATHOLOGY (2003)
分享论文
